XML 94 R79.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation - Stock Option Information Related to Equity Incentive Plan (Details)
12 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Options  
Outstanding, beginning of period (in shares) | shares 559,001
Assumed upon Boston Private acquisition (in shares) | shares 28,724
Granted (in shares) | shares 59,981
Exercised (in shares) | shares (169,045)
Forfeited (in shares) | shares (3,035)
Outstanding, end of period (in shares) | shares 475,626
Vested and expected to vest (in shares) | shares 448,844
Exercisable (in shares) | shares 207,472
Weighted average exercise price  
Outstanding, beginning of period (usd per share) $ 191.29
Assumed upon Boston Private acquisition (usd per share) 330.75
Granted (usd per share) 569.14
Exercised (usd per share) 152.00
Forfeited (usd per share) 278.80
Outstanding, end of period (usd per share) 260.77
Vested and expected to vest (usd per share) 255.96
Exercisable (usd per share) $ 201.61
Weighted Average Remaining Contractual Life in Years  
Outstanding (in years) 4 years 3 months 14 days
Vested and expected to vest (in years) 4 years 1 month 28 days
Exercisable (in years) 3 years
Aggregate Intrinsic Value of In-The-Money Options  
Outstanding | $ $ 199,397,510
Vested and expected to vest | $ 190,270,540
Exercisable | $ $ 98,888,120
Closing stock price $ 678.24